Nexalis Therapeutics LimitedASX: NX1

Ethics Approval for Phase 2 Clinical Trial of IRX-211

Nov 15, 2024 at 3:54 AM UTC · Issued by Nexalis Therapeutics Limited

Nexalis Therapeutics Limited has released a press release.

View Attachment